Exhaled nitric oxide as an indicator of severity of asthmatic inflammation.
Traditional assessment of severity of asthma relies on an evaluation of signs and symptoms and pulmonary function tests. These pulmonary function tests, such as peak expiratory flow rates, forced vital capacity, and forced expiratory flow rates, are indirect measures of airway caliber only, and not inflammation. Since asthma is an inflammatory disease, a measure of the degree of inflammation would be helpful in quantitating severity and titrating of anti-inflammatory therapy. A noninvasive method for measuring pulmonary inflammation would therefore be helpful to assist the emergency physician in initial treatment and assist in titration of anti-inflammatory therapy during repeat visits. Exhaled nitric oxide (NO) assays are convenient and practical and may fulfill this role. In this review, we discuss the role of NO in asthmatic inflammation and the role that exhaled NO values may play in the emergency management of asthma.
DeNicola
L R
LR
University of Florida Health Sciences Center, Jacksonville 32207, USA.
Kissoon
N
N
Duckworth
L J
LJ
Blake
K V
KV
Murphy
S P
SP
Silkoff
P E
PE
D001249:Asthma / Q000145:classification* / Q000378:metabolism* / Q000503:physiopathology; D001944:Breath Tests / Q000295:instrumentation / Q000379:methods; D002648:Child; D004635:Emergency Medicine; D006801:Humans; D007249:Inflammation / Q000145:classification / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D009569:Nitric Oxide / Q000032:analysis* / Q000096:biosynthesis; D012016:Reference Values; D012119:Respiration; D012720:Severity of Illness Index
D009569:Nitric Oxide